Duration of Protection From Pneumonia After Pneumococcal Vaccination in Hemodialysis Patients
- Conditions
- CKD (Chronic Kidney Disease) Stage 5DPneumonia
- First Posted Date
- 2017-11-22
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 792
- Registration Number
- NCT03350425
- Locations
- 🇩🇪
Eberhard Karls University Tübingen, Tübingen, BW, Germany
🇩🇪University Hospital Bonn, Bonn, NRW, Germany
🇩🇪Medical Clinic, Research Center Borstel, Borstel, SH, Germany
Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
- Conditions
- Stage II Grade 2 Follicular LymphomaStage I Follicular Lymphoma Grade 1Stage II Follicular Lymphoma Grade 2Stage II Grade 1 Follicular Lymphoma
- Interventions
- Radiation: Low dose radiation Therapy (LDRT)
- First Posted Date
- 2017-11-14
- Last Posted Date
- 2023-11-30
- Lead Sponsor
- Heidelberg University
- Target Recruit Count
- 89
- Registration Number
- NCT03341520
- Locations
- 🇩🇪
University of Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany
🇩🇪Vivantes Klinikum, Berlin, Germany
🇩🇪University of Cologne, Cologne, Germany
Theta-Burst-Stimulation in Recurrent Stroke Recovery
- Conditions
- NeurorehabilitationStroke
- Interventions
- Device: Magstim Super Rapid2 System
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- University Hospital of Cologne
- Target Recruit Count
- 60
- Registration Number
- NCT03337867
- Locations
- 🇩🇪
Christian Grefkles, Cologne, Germany
Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Drug: APX001 with Standard of Care anti-fungal agent
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Basilea Pharmaceutica
- Target Recruit Count
- 20
- Registration Number
- NCT03333005
- Locations
- 🇩🇪
University of Munich, Grosshadern Campus, Munich, Germany
🇩🇪Johannes Gutenberg, University of Mainz, Mainz, Germany
🇩🇪University of Cologne, Center for Integrated Oncology (CIO), Cologne, Germany
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
- Conditions
- Nosocomial InfectionClostridium Difficile InfectionVRE InfectionMRGN Bacteria
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2020-07-31
- Lead Sponsor
- University Hospital of Cologne
- Target Recruit Count
- 80000
- Registration Number
- NCT03250104
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, NRW, Germany
Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy
- Conditions
- Invasive Aspergillosis
- Interventions
- Other: Registry
- First Posted Date
- 2017-07-18
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- University Hospital of Cologne
- Target Recruit Count
- 203
- Registration Number
- NCT03221075
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, NRW, Germany
🇳🇱Radboud University Nijmegen Medical Center, Nijmegen, Netherlands
Rehabilitating (Stroke-induced) Apraxia With Direct Current Stimulation
- Conditions
- ApraxiaStroke
- Interventions
- Device: sham tDCSDevice: anodal tDCS
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2022-05-20
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 117
- Registration Number
- NCT03185234
- Locations
- 🇩🇪
Rehabilitationszentrum Godeshöhe e.V., Bonn, NRW, Germany
🇩🇪MediClin Fachklinik Rhein/Ruhr für Neurologie, Essen, NRW, Germany
Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT)
- Conditions
- Acute Myeloid LeukemiaGraft-versus-host-diseaseAllogeneic Hematopoietic Stem Cell TransplantationStem Cell Transplant Complications
- First Posted Date
- 2017-05-10
- Last Posted Date
- 2017-07-19
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 120
- Registration Number
- NCT03148197
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, Germany
Incidence and Economic Burden of Clostridium Difficile Infections (CDI) in the German Health Care System (IBIS)
- Conditions
- Clostridium Difficile DiarrheaClostridium Difficile Infection
- Interventions
- Other: Treatment of CDI
- First Posted Date
- 2017-05-05
- Last Posted Date
- 2018-03-15
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 541
- Registration Number
- NCT03141775
- Locations
- 🇩🇪
Städtisches Klinikum München, Munich, Bavaria, Germany
🇩🇪University Hospital Jena, Jena, Thuringia, Germany
🇩🇪University Clinical Center Hamburg-Eppendorf, Hamburg, Germany
Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe
- Conditions
- Perennial Allergic Rhinitis
- Interventions
- Drug: Acarovac
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- University Hospital of Cologne
- Target Recruit Count
- 32
- Registration Number
- NCT03127436
- Locations
- 🇦🇹
Praxis für Lungenheilkunde, Wien, Austria